Please assess the completion status of the following clinical trial:

Trial Title: A Brief Community Linkage Intervention for Dually Diagnosed Individuals

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male and female patients over 18 years old.~2. Patients who have a substance abuse disorder and a diagnosis of schizophrenia, schizoaffective disorder, or bipolar I disorder.~3. Patients seeking outpatient treatment for the above disorders from the VA.~4. Physically mobile~5. Agree to take public transportation if they do not have other private sources.~Exclusion Criteria:~1. Patients who only have either a mental health problem, or a substance abuse problem, but not both.~2. Patients who do not have a residence where they can stay upon discharge from the hospital.~3. Patients who are not sufficiently medically or psychiatrically stable to participate in residential or outpatient treatment. Those patients could be re-evaluated for the study once stabilized.~4. Patients exclusively engaged in methadone maintenance programs.~5. Patients who represent a serious suicide risk.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): This group will receive treatment as usual on Acute Psychiatry and at the Day Treatment Center along with an enhanced Time Limited Case Management community linkage intervention (TLC). Patients assigned to TLC will be offered enhanced services that begin on Acute Psychiatry and continue for a total of eight weeks through the community and Day Treatment Center transition.
- Arm 2 (Type: ACTIVE_COMPARATOR): This group will receive treatment as usual in Acute Psychiatry and at the Day Treatment Center in addition to participating in four group and one individual health education sessions (i.e., the attention control group). The length of the health education sessions (four group sessions and one individual session) will match the amount of attention provided to the treatment group. The health education sessions will cover topics such as nutrition, disease prevention, injury prevention, and healthy aging.

Based on this trial design, predict the completion outcome and termination type (if applicable).